Background In general, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection during pregnancy is not considered to be an increased risk for severe maternal …

Objective Objective evaluation of disease activity is challenging in patients with juvenile
dermatomyositis ( DM ) due to a lack of reliable biomarkers, but it is crucial to avoid both under‐ …

Background Treatment of juvenile idiopathic arthritis (JIA) has changed dramatically since
the introduction of biological agents in 1999. Objective To evaluate trends in prescription …

Objective JDM is a rare chronic immune-mediated inflammatory disease with a predominant
role for type I IFN responses. We aimed to determine the potential of Siglec-1 expression on …

Objective Juvenile dermatomyositis ( DM ) is a heterogeneous systemic immune‐mediated
vasculopathy. This study was undertaken to 1) identify inflammation/endothelial dysfunction–…

Rheumatology Vol. 43 No. 4 ß British Society for Rheumatology 2004; all rights reserved of
immunosupressive medication. Because of persistent disease activity and steroid …

Introduction In general SARS-CoV-2-infection during pregnancy is not considered to be an
increased risk for severe maternal outcomes, but has been associated with an increased risk …

We present 3 patients with juvenile dermatomyositis (JDM) and severe central nervous system
(CNS) complications. All patients had at least 4 positive criteria of Bohan and Peter, which …

Objectives To observe if capillary patterns in childhood-onset SLE (cSLE) change over time
and find associations between a capillary scleroderma pattern with disease activity, damage …

Objectives: In juvenile dermatomyositis (JDM), a heterogeneous systemic immune-mediated
vasculopathy, we aim to 1) identify inflammation/endothelial dysfunction-related biomarker …